Mahvash disease: A novel case of apparent monoallelic disease and a novel cause of hypoglycaemia
Glucagon cell hyperplasia and neoplasia (GCHN), also known as Mahvash disease (MVAH), is a rare pancreatic neuroendocrine disorder. In most cases, the disorder is autosomal recessive and caused by inactivating mutations in the glucagon receptor (GCGR), leading to pancreatic α-cell hyperplasia and hyperglucagonemia, with sporadic association with hypoglycaemia. We present an adult female patient presenting with recurrent hypoglycaemia: she had an enlarged pancreas and very high levels of glucagon. Severe hypoglycaemia is not generally seen in most cases of Mahvash syndrome; this could suggest the possibility of an occult insulinoma. Genetic testing showed an essential splice variant in GCGR that predicts loss of protein production. It is most likely a single pathogenic variant in the GCGR gene, although the literature reports only a recessive phenotype. We cannot entirely exclude an autosomal recessive condition in terms of mutations in promoter or relevant intronic regions.
Authors
- Bernard Chong Eu Khoo (ORCID: https://orcid.org/0000-0002-4223-9736)
- Márta Korbonits (ORCID: https://orcid.org/0000-0002-4101-9432)
- Martyn Evan Caplin (ORCID: https://orcid.org/0000-0003-0177-1352)
- Ashley Barry Grossman (ORCID: https://orcid.org/0000-0003-1176-6186)
- Sayka Barry (ORCID: https://orcid.org/0000-0002-3541-6474)
- Bano Gul (ORCID: https://orcid.org/0000-0003-0470-0461)
- Heung Chong
- N. Beharry
Institutions
- Queen Mary University of London (GB)
- The Royal Free Hospital (GB)
- City St George's, University of London (GB)
- University College London (GB)
Publication Details
- Journal
- Endocrine Oncology
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1530/eo-26-0063
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00